Houston, TX 的 克隆氏症 臨床試驗
17 項針對 克隆氏症 的研究正在 Houston（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
招募中3 期
- Baylor College of Medicine Medical Center ( Site 5020), Houston
- Michael E. DeBakey VA Medical Center ( Site 5086), Houston
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
招募中2 期
- Integrity Advanced Therapeutics /ID# 283871, Houston
- Novel Research - Bellaire /ID# 280925, Bellaire · 距離 7 英里
A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
招募中4 期
- Kelsey Research Foundation, Houston
- MedCare Pharma LLC, Houston
- Spring Clinical Research, Houston
Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
招募中2 期
- Houston Methodist Hospital /ID# 265533, Houston
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
招募中2/3 期
- Victorium Clinical Research, Houston
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
招募中2 期
- Novel Research, LLC, Bellaire · 距離 7 英里
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
招募中1 期
- UT MD Anderson Cancer Center, Houston
A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
招募中2 期
- The University of Texas Health Science Center at Houston, Houston
A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
招募中4 期
- The University of Texas Health Science Center at Houston, Houston
A Study to Assess the Long-Term Safety of Ustekinumab Versus Other Biologics in Patients With Crohn's Disease and Ulcerative Colitis
招募中觀察性研究
- BAMC, Houston
Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
招募中
- Baylor College of Medicine, Houston
Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors
招募中觀察性研究
- M D Anderson Cancer Center, Houston
A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)
招募中3 期
- Texas Children's Hospital - Baylor - PIN, Houston
A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)
招募中3 期
- Texas Children's Hospital, Houston
Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease
招募中2 期
- Houston Methodist Hospital, Houston
- Novel Research, LLC, Bellaire · 距離 7 英里
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
招募中2 期
- Mirador Therapeutics Selected Site, Houston
VECTORS - A Study to Evaluate Transmural Healing as a Treatment Target in Crohn's Disease
招募中4 期
- Houston Methodist Hospital, Houston
其他城市的 克隆氏症 試驗
- New York City, NY35 項研究
- Cleveland, OH19 項研究
- St. Louis, MO19 項研究
- Boston, MA19 項研究
- Miami, FL19 項研究
- Orlando, FL17 項研究
- Atlanta, GA17 項研究
- Tyler, TX16 項研究
- San Diego, CA15 項研究
- San Antonio, TX15 項研究
- Los Angeles, CA15 項研究
- Philadelphia, PA13 項研究
Houston 的其他研究
- 非小細胞肺癌145 項研究
- 乳癌126 項研究
- 癌症（所有類型）121 項研究
- 轉移性癌症104 項研究
- 大腸直腸癌102 項研究
- 卵巢癌89 項研究
- 急性髓系白血病85 項研究
- 肺癌78 項研究
- 前列腺癌76 項研究
- 子宮內膜癌68 項研究
- 胰臟癌61 項研究
- 黑色素瘤59 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月5日。各研究自行設定資格標準；由研究團隊決定參與者資格。